Loading clinical trials...
Loading clinical trials...
Evaluating Assessment and Medication Treatment of ADHD in Children with Down Syndrome
Conditions
Interventions
Quillivant XR
Placebo
Locations
4
United States
University of California Davis MIND Institute
Sacramento, California, United States
Boston Children's Hospital
Boston, Massachusetts, United States
Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio, United States
University of Pittsburgh Medical Center
Pittsburgh, Pennsylvania, United States
Start Date
October 2, 2020
Primary Completion Date
September 30, 2025
Completion Date
September 30, 2025
Last Updated
January 15, 2025
NCT07478458
NCT07465081
NCT07314333
NCT04726241
NCT07189442
NCT07234695
Lead Sponsor
Children's Hospital Medical Center, Cincinnati
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions